The largest database of trusted experimental protocols

11 protocols using mouse il 12

1

NK Cell Activation and Degranulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
100,000 NK cells were incubated in 96-well tissue culture plates coated with anti-NK1.1 (clone PK136) or isotype-matched control mouse IgG2a as described previously (Nabekura et al., 2015 (link)); incubated with 2.5 ng/ml mouse IL-12 and 2.5 ng/ml mouse IL-18 (R&D Systems); or co-cultured with 105 RMA, RMA expressing m157, or RMA expressing Rae1γ for 5 h at 37°C in the presence of PE-conjugated anti-CD107a mAb and GolgiStop (BD), followed by staining for surface molecules and intracellular IFN-γ as previously described (Nabekura and Lanier, 2014 (link)).
+ Open protocol
+ Expand
2

Cytokine Combination Immunotherapy Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines used include mouse IL-12, (R&D Systems), human IL-12 (BD PharMingen), human IL-2 (Peprotech), IFN-β (Betaseron, Bayer), B18R (R&D systems), MYD88 inhibitor peptide or control peptide (Novus), PAM3CSK4, poly I:C, heat killed M. tuberculosis, heat killed S. typhimurium (InvivoGen).
+ Open protocol
+ Expand
3

Cytokine-Mediated Immune Response Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines used include mouse IL-12, (R&D Systems), human IL-12 (BD PharMingen), human IL-2 (Peprotech), IFN-β (Betaseron, Bayer), B18R (R&D systems), MYD88 inhibitor peptide or control peptide (Novus), PAM3CSK4, poly I:C, heat killed M. tuberculosis, heat killed S. typhimurium (InvivoGen).
+ Open protocol
+ Expand
4

Activation and Expansion of NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
One million splenocytes from mixed BM chimeric mice were incubated in 96-well tissue culture plates coated with anti-NKp46 (29A1.4) as described (5 (link)), or with 10 ng/ml mouse IL-12 plus 10 ng/ml mouse IL-18 (R&D Systems), 10 ng/ml PMA plus 1 μg/ml ionomycin (Sigma-Aldrich), or co-cultured with 1 × 105 RMA or m157-transfected RMA cells as described (6 (link)). One million CellTrace Violet-labeled splenocytes were co-cultured with 1 × 105 RMA or m157-transfected RMA cells (fixed in 1% paraformaldehyde) in the absence or presence of 25 ng/ml mouse IL-33 (R&D) and/or 10 ng/ml mouse IL-12 with 50 U/ml human IL-2 (NCI) for 4 days at 37° C.
+ Open protocol
+ Expand
5

Cytokine and Degranulation Assays for NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes (1 × 106) from mixed WT and dKO BM chimeric mice were incubated in 96-well tissue culture plates coated with anti-NK1.1 (PK136) or control mouse IgG2a (39 (link)). For cytokine response testing, 1 × 106 splenocytes from mixed WT and dKO BM chimeric mice were incubated with 2.5 ng/ml mouse IL-12 and 2.5 ng/ml mouse IL-18 (R&D Systems). To test degranulation, 1 × 106 splenocytes from mixed WT and dKO BM chimeric mice were co-cultured with either 1 × 105 untransfected or m157-transfected B6 3T3 cells for 5 h at 37° C with PE-conjugated anti-CD107a (clone 1D4B) and GolgiStop (BD Biosciences), followed by staining for surface molecules and intracellular IFN-γ. For assessment of phosphorylated STAT4 and STAT1, 1–3 × 106 splenocytes were cultured with 20 ng/ml mouse IL-12 for 30 min or 1000 U/ml mouse IFN-α (PBL Assay Science) for 10 min, fixed, and stained with AlexaFluor 647-conjugated phosphorylated STAT4 (pY693, clone 38/p-Stat4) or PE-conjugated phosphorylated STAT1 (pY701, clone 4a) (BD Biosciences) (40 (link)).
+ Open protocol
+ Expand
6

Murine NK Cell Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 2–4 × 104 mouse NK cells were purified and stimulated for 3 h in RPMI plus medium supplement (10% FBS, 1× sodium pyruvate, 1× l-glutamine, 1× pen/strep, 1× MEM-NEAA) with 20 ng ml−1 mouse IL-2 (Thermo Fisher Scientific), 20 ng ml−1 mouse IL-15 (R&D Systems), 20 ng ml−1 mouse IL-12 (R&D Systems), 10 ng ml−1 mouse IL-18 (MBL) and/or 100 IU mouse IFN-α (R&D Systems). Cells were cultured in medium alone as unstimulated controls.
+ Open protocol
+ Expand
7

Assessing NK Cell Activation and Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells from spleen, GLN, liver, small intestine and vaginas were plated for 4h at 37°C in U-bottom 96 well plates and incubated with either PMA (200 ng/mL, Sigma-Aldrich) and ionomycin (0.5 μg/mL, Sigma-Aldrich) or mouse IL-12 (20 ng/mL, R&D Systems) and mouse IL-18 (5 ng/mL, MBL) or in the presence of YAC-1 tumor target cells at a 1:1 ratio or mouse IL-23 (20ng/ml) and mouse IL1β (20ng/ml). In addition, cells were incubated for 4h in high-affinity Immulon flat-bottom 96 well plates coated with 25 μg/mL of anti-mouse NK1.1 or anti-mouse IgG1 mAb. NK cell degranulation was assessed after CD107a staining and IFN-γ production evaluated in presence of monensin and brefeldin A (BD Biosciences).
+ Open protocol
+ Expand
8

NK cell activation and STAT4/STAT1 phosphorylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enriched NK cells (naive or memory) were incubated with 20 ng/ml mouse IL-12 (R&D Systems) + 10 ng/ml IL-18 (R&D Systems) for 6 h at 37°C in the presence of PE-conjugated anti-CD107a mAb and GolgiStop (BD), followed by staining for surface molecules and intracellular cytokines. For the phospho-STAT4 assay, enriched NK cells (naive plus memory, CD45 congenically marked) were cultured with 2, 5, 10, 20, or 50 ng/ml of IL-12 for 5, 10, 30, or 90 min at 37°C. Cells were fixed (1.6% paraformaldehyde in phosphate-buffered saline), permeabilized with 90% methanol, and stained with an antibody against pSTAT4 (Alexa Fluor 647–conjugated anti–STAT4-pY693; BD). For the phospho-STAT1 assay, enriched NK cells (naive plus memory, CD45 congenically marked) were cultured with 5,000 U/ml IFN-β (PBL Assay Science) for 30 or 90 min at 37°C; cells were fixed as for pSTAT4 and stained with pSTAT1 (PE-conjugated anti–STAT1-pY701; BD).
+ Open protocol
+ Expand
9

Naïve T Cell Differentiation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve T cells (CD4+CD62LhighCD25-) were isolated from lymph nodes and spleen by magnetic sorting (T cell isolation kit II, mouse; Miltenyi Biotec, Germany). Purity was in general higher than 95% as controlled by FACS staining. Naïve T cells were stimulated for 3 to 5 days with plate-bound antibody to CD3 (145-2C11, 4 μg/ml) and antibody to CD28 (PV-1, 2 μg/ml). Recombinant cytokines were added to the differentiation cultures as indicated: human TGF-β1 (2 ng/ml) and mouse IL-6 (50 ng/ml) for Th17, mouse IL-12 (10 ng/ml) and anti-IL-4 (10 μg/ml) for Th1, all R&D Systems.
+ Open protocol
+ Expand
10

Suppressive Capacity of MDSC on T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The suppressive capacity of MDSC was determined by co-culture with pan T cells. Isolated pan T cells from healthy mice and MDSCs from 4T1 tumor bearing mice were used as responder cells and stimulator cells, respectively. Responder and stimulator cells were then mixed at a 1:10 ratio and T cell proliferation was assessed by thymidine incorporation. Briefly, 106 splenic MDSCs in complete RPMI 1640 media were plated with 105 pan T cells in a 96-well plate. Pan T cells were activated with anti-CD3 (0.5 µg/mL) and anti-CD28 (0.5 µg/mL) for 4 days and maintained with or without mouse IL-12 (10 ng/mL, R&D systems) as previously reported.13 (link) Subsequently, [3H] thymidine (1 µCi/well) was added to the wells for the last 16hr of the 4 day culture periods. Responses are expressed as the mean counts per minute (cpm).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!